Cobimetinib
About
Therapy type: Targeted therapy
Therapy strategy: MEK inhibition
Mappings
NCI Thesaurus: Cobimetinib (coding:ncit:C68923)
RxNorm: cobimetinib (coding:rxcui:1722365, coding:omop:37395721)
SNOMED: Cobimetinib (coding:sctid:715257001, coding:omop:35605804)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | BRAF p.V600E | Melanoma | Atezolizumab, Cobimetinib, Vemurafenib | |
| FDA (1) | BRAF p.V600K | Melanoma | Atezolizumab, Cobimetinib, Vemurafenib | |
| FDA (1) HC (1) | BRAF p.V600E | Melanoma | Cobimetinib, Vemurafenib | |
| FDA (1) HC (1) | BRAF p.V600K | Melanoma | Cobimetinib, Vemurafenib |